[PLX] QoQ Quarter Result on 30-Jun-2018 [#Q2]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
09-Aug-2018
Financial Year
2018
Quarter
30-Jun-2018 [#Q2]
Profit Trend
QoQ- -20.15%
YoY- -2,609.78%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
Revenue 10,439 27,018 663 2,006 4,553 2,469 7,526 24.39%
PBT -7,264 9,781 -15,544 -11,294 -9,400 -15,141 -11,437 -26.13%
Tax 190 99 230 75 132 916 8 727.84%
NP -7,264 9,781 -15,544 -11,294 -9,400 -15,141 -11,437 -26.13%
Tax Rate - -1.01% - - - - - -
Total Cost 17,703 17,237 16,207 13,300 13,953 17,610 18,963 -4.48%
Ratio Analysis
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
NP Margin -69.59 36.20 -2,344.49 -563.01 -206.46 -613.24 -151.97 -40.61%
Per Share
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
EPS -0.49 0.66 -1.05 -0.77 -0.65 -1.08 -0.86 -31.29%
EPS Diluted -0.49 0.66 -1.05 -0.77 -0.65 -1.04 -0.86 -31.29%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.